APA (7th ed.) Citation

Wu, Y., Hong, C., Wang, Y., Huang, W., Yeh, Y., Wang, B., . . . Chiu, H. (2017). A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer. Cancer letters, 400, 79-88. https://doi.org/10.1016/j.canlet.2017.04.023

Chicago Style (17th ed.) Citation

Wu, Yuan-Hua, Chi-Wei Hong, Yi-Ching Wang, Wei-Jan Huang, Ya-Ling Yeh, Bour-Jr Wang, Ying-Jan Wang, and Hui-Wen Chiu. "A Novel Histone Deacetylase Inhibitor TMU-35435 Enhances Etoposide Cytotoxicity Through the Proteasomal Degradation of DNA-PKcs in Triple-negative Breast Cancer." Cancer Letters 400 (2017): 79-88. https://doi.org/10.1016/j.canlet.2017.04.023.

MLA (9th ed.) Citation

Wu, Yuan-Hua, et al. "A Novel Histone Deacetylase Inhibitor TMU-35435 Enhances Etoposide Cytotoxicity Through the Proteasomal Degradation of DNA-PKcs in Triple-negative Breast Cancer." Cancer Letters, vol. 400, 2017, pp. 79-88, https://doi.org/10.1016/j.canlet.2017.04.023.